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Recurrent tumors inside an orthotopic ileal neobladder are rare, and only few cases have been reported in the
literature. Herein, we report a case of recurrent transitional cell carcinoma in an orthotopic ileal neobladder
discovered one and a half years after the operation.
© 2015 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. All rights reserved.
Introduction
Secondary malignancies developing inside neobladders following
intestinal urinary diversion are not uncommon. According to Stewart
et al., tumor growth after colonic diversion may be due to the effect
of fecal bacteria on urinary nitrate leading to the development of
nitrosamine which is an active carcinogen [1]. Meanwhile, urothelial
carcinoma recurrence in an orthotopic ileal neobladder is extremely
rare with less than 10 cases reported to date [2,3]. We present
the case of a female patient with isolated recurrent transitional
cell carcinoma (TCC) in an ileal neobladder, diagnosed 18 months
after radical cystectomy and modified Hautmann ileal bladder
substitution.
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Case  report
In February 2010, a 59-year-old female had been diagnosed with
high-grade muscle-invasive TCC of the bladder (pT2) after perform-
ing investigations for lower urinary tract symptoms of 3 months’
duration. She was subjected to radical cystectomy and creation of
a modified Hautmann orthotopic ileal neobladder. All postopera-
tive surgical margins were negative (high grade, stage pT2N0M0).
On follow-up 18 months later, the patient reported gross hema-
turia. Abdominal ultrasound showed an echogenic growth within the
neobladder. Multiplanar MRI revealed the presence of a lesion with
restricted diffusion, indicative of a neoplastic nature, and absence
of lymphadenopathy (Fig. 1).
Cystoscopic examination revealed multifocal papillary tumors sized
about 4 cm ×  5 cm and 3 cm ×  2 cm in the region of the right and
left lateral walls of the pouch, respectively. The urethra and urethro-
enteric anastomosis were tumor-free. Laboratory work-up revealed
normal results (Fig. 2).
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Figure  1  Multiplaner MRI showing recurrent tumor inside the
neobladder.
Figure  2  Cystoscopic picture of the lesion.
The patient refused to undergo pouchectomy with ileal con-
duit diversion and preferred to retain her neobladder. Complete
transurethral resection of the tumors was performed in two ses-
sions due to their big size and to avoid perforation. The patient
was then subjected to postoperative radio-chemotherapy. Postop-
erative histopathologic examination of the recurrent lesions revealed
high-grade invasive TCC (Fig. 3). Follow-up cystoscopy and urine
cytology after completion of the adjuvant treatment were performed
every 3 months for a year. They revealed absence of any residual
lesion and a negative cytology. Upper urinary tract imaging per-
formed at the end of that year showed normal findings. The results
Figure  3  Histological details of the carcinoma (H&E ×200).
of follow-up investigations including upper urinary tract imaging
have been normal since then.
Discussion
Tumor recurrence after intestinal urinary diversion is not uncom-
mon. However, TCC recurrence or carcinoma in situ (CIS) after
radical cystectomy and orthotopic ileal neobladder substitution is
extremely rare [4–8]. We herein present a new case of TCC recur-
rence in an ileal neobladder, diagnosed 18 months after radical
cystectomy.
Tumors secondary to urinary diversion using isolated gut segments
are mostly adenomas and adenocarcinomas (72.6%), while TCC,
squamous cell carcinoma, signet ring cell carcinoma, small cell car-
cinoma, and leiomyosarcoma altogether represent only 27.4% [9].
The whole urinary tract is at risk of developing new urothelial tumors
after treatment of a previous one, as TCC recurrence is either due
to field change or implantation [4].
The most common site for recurrence after orthotopic neobladder
substitution is the urethra with a reported incidence of 0.7–18% [10].
In our case, the urethra was not affected, as the tumor was located
entirely inside the neobladder. Our case also showed the potential
of TCC to develop not only in the bladder urothelium, but also in
the ileal mucosa of a neobladder as previously described by Herawi
and colleagues. They reported urothelial carcinoma recurrence in
the peritoneum and on the colonic mucosal surface of a neobladder,
which used to be considered unusual sites for recurrence according
to the “seed and soil hypothesis” [11].
Although rare, TCC development inside the ileal neobladder should
be considered in any patient with a change in voiding habits or hema-
turia after bladder substitution. The role of conservative surgery in
those patients, taking into consideration the patient’s wishes and/or
the question, whether the patient is fit for major surgery, should be
studied well.
Long-term follow-up of these cases is required to assess the effec-
tiveness of conservative treatment for this uncommon type of
recurrent tumor inside the ileal neobladder.
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